Financial Considerations and Access to Abiraterone in the USA
Abiraterone, a crucial medication for treating advanced prostate cancer, has been a game-changer for patients with metastatic castration-resistant prostate cancer (mCRPC). However, for many, the Abiraterone price in USA represents a significant financial challenge. With costs ranging from $8,000 to $12,000 per month, understanding the factors behi